Advanced Alcohol Rehab
The ReNova Method is a significant step forward in the treatment of Alcohol Use Disorder. ReNova is made possible by advances in understanding from neuroscience and psychology.
ReNova reduced alcohol use to an average of 2-3 drinks per episode from a previous average 9-21 drinks per episode for those with moderate to severe alcohol use disorder.ReNova works by changing your relationship with alcohol, ending the obsessive drive to drink beyond a reasonable limit, thereby restoring choice and control.
And, unlike other ways of achieving alcohol moderation, such as the Miller Approach or The Sinclair Method, ReNova doesn't rely on either willpower (which often fails) or powerful doses of medication that can have even more powerful side effects.
Instead, the ReNova Method creates an automatic internal response that operates like the response of non-alcohol abusers. After a few drinks a powerful feeling of desire to stop 'kicks in' and you effortlessly stop drinking... because that is what you want.
ReNova has a high rate of success in good candidates for this approach. 6/7 persons with moderate to severe Alcohol Use Disorder that are trained in ReNova were still moderate in their alcohol use @ 12 months post-training.
Want to find out if ReNova can change how you relate to alcohol, restoring your control? Get a free consultation today to learn more.
The ReNova Method
See FAQs below
ReNova Frequently Asked Questions
Q. What is ReNova?
A. It is a promising combination rehab process that has shown better outcomes for recovery than standard 12 step approaches and can be used for successful alcohol moderation.
Q. Is the ReNova Method a variation of the Sinclair Method?
A. No. While ReNova and Sinclair operate on the same principle (conditioned response training) and achieve the same high outcomes, The ReNova Method is able to avoid the strong side effects that can make the Sinclair Method unworkable for many people. That is because ReNova uses an entirely different way to achieve the goal.
Q. Is ReNova experimental?
A. While the combination of methods is novel to ReNova, each component is well researched, FDA approved/cleared or endorsed by the American Psychological Association as an approved therapy. The particular combination of these approved approaches has been shown to have a synergistic effect.
Q. Is ReNova complicated or time-consuming?
A. No. While ReNova is comprehensive, it is easy to understand, easy to do with proper training, and is progressively more effective with experience and practice.
Q. Is ReNova really effective for alcohol moderation?
A. ReNova has been shown to be highly effective for alcohol moderation in good candidates with moderate to severe alcohol use disorder. ReNova reduced alcohol use to 2-3 drinks per episode from an average of 9-21 drinks prior to ReNova.
Q. How long is the ReNova program?
A. The initial program of alcohol rehab using ReNova is 12 weeks with twice-weekly training/counseling sessions of 1-hour length. Follow up visits are scheduled once monthly for the 1st year. Quarterly follow-ups occur thereafter as needed.
Q. Is there anything painful or uncomfortable about ReNova?
Q. Is everyone a good candidate for ReNova?
A. While many people with alcoholism are good candidates, ReNova is contraindicated in persons with: co-occurring disorders of bi-polar and schizophrenia, persons with severe liver, heart or kidney damage, or Wernicke's encephalopathy and women who are pregnant.
Q. Can ReNova be used to treat other addictions?
A. ReNova has not been tested on non-substance related or 'process' addictions. Clients with some of these co-occurring addictions have reported a lessening of compulsive gambling, compulsive sexual addiction, and compulsive shopping. Due to ethical and legal considerations ReNova has not been tested for drug abuse.
Q. How was ReNova developed?
A. ReNova was developed over a series of several years at DayRise Recovery, an award-winning licensed multi-disciplinary treatment center. Michael O'Neal, LCDC-ADC III, the DayRise Center Director was the chief developer in collaboration with two physicians, one a psychiatrist, and the other a doctor of rehabilitative medicine.